STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Astera Labs, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Astera Labs' Form 144 discloses a proposed sale of 26,000 common shares on NASDAQ through broker Stifel, with an aggregate market value of $4,556,737.00 and the issuer reported 162,150,000 shares outstanding. The filing shows the shares were acquired in private placements: 1,000 on 05/17/2022 and 25,000 on 11/08/2019. A related sale by Stefan A Dyckerhoff of 26,000 shares on 08/07/2025 for $4,508,959.00 is also listed. The notice includes the seller's representation that they do not possess undisclosed material adverse information and contains the standard legal warning about intentional misstatements.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Form 144 discloses a proposed sale of 26,000 ALAB common shares via Stifel on NASDAQ.

The filing specifies the intended transaction size (26,000 shares) and the stated aggregate market value ($4,556,737.00), plus the company's outstanding share count (162,150,000). It also documents prior acquisitions by the filer through private placements and a recent sale by Stefan A Dyckerhoff on 08/07/2025. The form contains the seller's certification regarding material nonpublic information, consistent with normal Rule 144 disclosures.

TL;DR: Filing includes required seller representations and a transaction record; it documents acquisition dates and a recent sale.

The notice includes explicit acquisition history (private placements on 11/08/2019 and 05/17/2022), the broker on record (Stifel), and the seller's declaration about undisclosed material information. Those elements align with Rule 144 procedural disclosure requirements and provide a clear audit trail for the reported transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ALAB Form 144 disclose?

The filing notifies a proposed sale of 26,000 common shares of Astera Labs (ALAB) via broker Stifel on NASDAQ with aggregate market value $4,556,737.00.

Who is the seller named in the Form 144?

The filing lists Stefan A Dyckerhoff as a related seller and shows a reported sale by him of 26,000 shares on 08/07/2025 for $4,508,959.00.

When is the approximate sale date and which exchange is listed?

The filing lists the approximate date of sale as 08/08/2025 and the exchange as NASDAQ.

How were the shares being sold originally acquired?

The shares were acquired in private placements: 25,000 shares on 11/08/2019 and 1,000 shares on 05/17/2022, with payment noted as cash.

How many shares does the issuer report outstanding?

The filing shows 162,150,000 shares outstanding for the issuer.
ASTERA LABS INC

NASDAQ:ALAB

ALAB Rankings

ALAB Latest News

ALAB Latest SEC Filings

ALAB Stock Data

23.95B
149.03M
12.94%
72.6%
5.54%
Semiconductors
Semiconductors & Related Devices
Link
United States
SAN JOSE